Literature DB >> 27348200

The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates.

Michael A Dunn1,2, Deborah A Josbeno3, Amy R Schmotzer4,5, Amit D Tevar5,6, Andrea F DiMartini5,7, Douglas P Landsittel5,8, Anthony Delitto3.   

Abstract

Frailty with sarcopenia in cirrhosis causes liver transplant wait-list attrition and deaths. Regular physical activity is needed to protect patients with cirrhosis from frailty. We subjectively assess physical performance in selecting patients for transplant listing, but we do not know whether clinical assessments reflect the extent of activity patients actually perform. To investigate this question, 53 wait-listed patients self-assessed their performance of ordinary physical tasks using the Rosow-Breslau survey, and clinicians assessed their physical performance status with the Karnofsky index. We compared these assessments with actual activity measured using an accelerometer/thermal sensing armband worn from 4 to 7 days. We found that their measured activity was among the lowest reported in chronic disease, similar to that of patients with advanced chronic pulmonary disease or renal failure. Their percentages of waking hours spent in sedentary, light, and moderate-vigorous activity were 75.9% ± 18.9%, 18.9% ± 14.3%, and 4.9% ± 6.9%, respectively. Higher mean sedentary and lower mean moderate-vigorous activity was significantly associated with 9 wait-list deaths (P = 0.004). Compared with a range of 7000-13,000 steps/day in healthy adults, patients' mean steps/day were 3164 ± 2842. Both their activity percentage and step data were typical of other severely inactive populations. Neither their Rosow-Breslau scores (mean 2.3 ± 0.8, maximum 3.0) nor their Karnofsky scores (mean 79 ± 12, maximum 100) suggested major impairment or showed a correlation with patients' actual physical performance. In conclusion, physical activity in patients with cirrhosis wait-listed for transplantation is highly sedentary. Self-assessments and provider assessments of physical activity do not reliably indicate actual performance. Whether the gap between assessed and actual performance may be favorably modified by interventions to improve activity and ameliorate frailty merits further study. Liver Transplantation 22 1324-1332 2016 AASLD.
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2016        PMID: 27348200     DOI: 10.1002/lt.24506

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  24 in total

Review 1.  Nutritional Intervention in Chronic Liver Failure.

Authors:  Mathias Plauth
Journal:  Visc Med       Date:  2019-08-21

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 3.  Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances.

Authors:  Jaividhya Dasarathy; Arthur J McCullough; Srinivasan Dasarathy
Journal:  Alcohol Clin Exp Res       Date:  2017-07-11       Impact factor: 3.455

4.  Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.

Authors:  Patrick McCabe; Artin Galoosian; Robert J Wong
Journal:  Dig Dis Sci       Date:  2019-10-22       Impact factor: 3.199

5.  Functional Status and Liver Disease Phenotype: Frailty, Thy Presence Is Ominous.

Authors:  Manhal Izzy; Alexandra Shingina
Journal:  Dig Dis Sci       Date:  2020-05       Impact factor: 3.199

Review 6.  Frailty Assessment in Patients with Liver Cirrhosis.

Authors:  Amanda C Van Jacobs
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-10-09

Review 7.  Hyperammonemia and proteostasis in cirrhosis.

Authors:  Srinivasan Dasarathy; Maria Hatzoglou
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2018-01       Impact factor: 4.294

8.  Hyperammonaemia-induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress.

Authors:  Gangarao Davuluri; Allawy Allawy; Samjhana Thapaliya; Julie H Rennison; Dharmvir Singh; Avinash Kumar; Yana Sandlers; David R Van Wagoner; Chris A Flask; Charles Hoppel; Takhar Kasumov; Srinivasan Dasarathy
Journal:  J Physiol       Date:  2016-10-23       Impact factor: 5.182

Review 9.  Physical Function, Physical Activity, and Quality of Life After Liver Transplantation.

Authors:  Michael A Dunn; Shari S Rogal; Andres Duarte-Rojo; Jennifer C Lai
Journal:  Liver Transpl       Date:  2020-05       Impact factor: 5.799

Review 10.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.